Catalyst Wire Dossier Catalyst Wire Dossier

Imatinib Teva B.V. (imatinib mesilate)

imatinib mesilate · Teva B.V.
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Imatinib Teva B.V. (imatinib mesilate), covering 2018-10-09 to 2018-10-09. Get the full timeline:

Most recent: EMA Withdrawn: Imatinib Teva B.V. (imatinib mesilate) — Teva B.V.

See pricing